重度のマラリアは,寄生虫が内皮タンパク質C受容体と結合することと関連しています
Louise Turner1, Thomas Lavstsen, Sanne S Berger
1Centre for Medical Parasitology, Department of International Health, Immunology & Microbiology, University of Copenhagen and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark. lturner@sund.ku.dk
Nature
|June 7, 2013
まとめ
重度のマラリアは,Plasmodium falciparumに感染した赤血球が血管に付着することを含む. 研究者らは,内皮タンパク質C受容体 (EPCR) がマラリアの特定のタンパク質の結合部位であり,疾患の重症度に影響を及ぼすことを発見しました.
科学分野:
- マラリア学 マラリア学
- 免疫学 免疫学とは
- 血管生物学 血管生物学
背景:
- 毎年約100万人の死者を引き起こす重度の小児マラリアは,Plasmodium falciparumに感染した赤血球の封じ込めによるものです.
- 隔離は,P. falciparumの赤血球膜タンパク質1 (PfEMP1) と内皮受容体間の相互作用に依存しています.
- 特定のPfEMP1サブタイプ (DC8とDC13) は重症マラリアと関連しているが,その受容体は特定されなかった.
研究 の 目的:
- DC8とDC13のPfEMP1変異体に対する内皮受容体を特定する.
- 重度のマラリアの病原性におけるPfEMP1-EPCR相互作用の分子メカニズムを解明する.
主な方法:
- PfEMP1受容体を特定するためのタンパク質-タンパク質相互作用の研究.
- PfEMP1結合ドメイン (CIDRα1) とそのEPCRとの相互作用の分析.
- タンパク質C経路へのPfEMP1結合の機能的影響を調査する.
主要な成果:
- 内皮タンパク質C受容体 (EPCR) は,DC8とDC13の受容体として特定されたPfEMP1.1.
- これらのPfEMP1変異のシステインに富んだインタードメイン領域 (CIDRα1) は,EPCR結合を媒介する.
- EPCRに結合するPfEMP1は,タンパク質Cの結合を阻害し,抗凝固と細胞保護経路を潜在的に破壊する.
結論:
- 重度のマラリア寄生虫からのPfEMP1は,タンパク質C媒介の細胞保護と抗凝固における重要な受容体であるEPCRと結合する.
- この相互作用は,寄生虫の粘着を重要な宿主経路と結びつけ,重度のマラリアの病原性についての洞察を提供します.
- このメカニズムの理解は,重度のマラリアに対する新しい治療戦略の開発を導くかもしれません.
さらに関連する動画
関連する概念動画
Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Drug Distribution: Plasma Protein Binding
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Diversity of Protists II
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...


